| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2969884 | The Journal of Heart and Lung Transplantation | 2016 | 22 Pages |
Abstract
These results confirm findings of the earlier Phase 2a trial and provide further support that ALN-RSV01 reduces the risk of BOS after RSV in LTx recipients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jens MD, Martin R. MD, Tony MD, A.W. MD, Urte MD, Daniel MD, FACP, Selim MD, John MD, Verena PhD, Shaily Shah, Brian R. PhD, Jeffrey MBA, Sara PhD, Jared MD, Akshay MD, Amy R. MD, Allan R. MD, MBBS,